Neta Barashi

Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?

Macrophages in immunoregulation and therapeutics

Inflammation and tumor progression: signaling pathways and targeted intervention

Natural product-based nanoformulations for cancer therapy: Opportunities and challenges

Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy

CCR5-Dependent Homing of T Regulatory Cells to the Tumor Microenvironment Contributes to Skin Squamous Cell Carcinoma Development

Contribution of monocytes and macrophages to the pathogenesis of systemic sclerosis: recent insights and therapeutic implications

Implication of Nano-Antioxidant Therapy for Treatment of Hepatocellular Carcinoma Using PLGA Nanoparticles of Rutin

Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy

CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1–Mediated ERK and BCL2/Cyclin D1 Pathways

Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis

Inflammation-Induced Hepatocellular Carcinoma Is Dependent on Ccr5 in Mice